The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar edges down, set for weekly loss; kiwi having best month since 2013

Fri, 27th Nov 2020 12:48

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E
(Updates prices, adds comment, adds detail)

By Elizabeth Howcroft

LONDON, Sept 7 (Reuters) - The dollar fell on Friday, close
to its lowest in three months and on track for a weekly loss
against a basket of currencies, as markets continued their rally
on vaccine progress and hopes for a global economic recovery.

The dollar has fallen more than 2.2% so far this month as
global market sentiment has surged following Joe Biden's U.S.
election victory, positive COVID-19 vaccine announcements and a
commodity surge, which lessened demand for the safe-haven
currency.

Sentiment was mixed in early London trading after several
scientists raised doubts about the success rate for the vaccine
developed by British drugmaker AstraZeneca, but European
shares picked up as the session went on.

AstraZeneca had said on Monday that its vaccine was 70%
effective in pivotal trials, and could be up to 90% effective -
the latest in a slew of positive vaccine announcements which had
boosted investor confidence, even as COVID-19 hospitalizations
reach record highs in the United States.

"The markets have a tendency to perhaps look through the
fact that we’re going to have a really nasty Q4, possibly a very
nasty Q1 too, in terms of economic data in Europe and the U.S.,
and look through to the better times ahead," said Jane Foley,
senior FX strategist at Rabobank.

"We’ve seen various stock market indices at all-time highs,
so the dollar under pressure. Also keeping the dollar under
pressure is this perception that the Fed will act, will pressure
the yield curve lower, if need be, particularly if there
continues to be a delay over the fiscal package," she said.

The U.S. Federal Reserve's latest meeting minutes said that
policymakers could give new guidance on bond-buying "fairly
soon".

At 1213 GMT, the dollar was down 0.1% on the day at 91.996
, having reached its lowest since Sept. 1 earlier in the
week.

ING strategists rote in a note to clients that the dollar
was likely to keep oscillating around the 92 level in the dollar
index on Friday in the absence of other catalysts.

Analysts said that volumes were lower as the United States
will have reduced trading hours on Friday, following the
Thanksgiving holiday on Thursday.

The Australian dollar - seen as a liquid proxy for risk -
hit its highest in nearly three months in early London trading
and was up 0.2% at 0.73735 at 1215 GMT.

Australia's second-largest state, Victoria, which was once
the country's COVID-19 hotspot, said on Friday that it has gone
28 days without detecting new infections.

The Kiwi dollar, which is having its best month since late
2013, was up 0.1% on the day at 0.7015.

"Clearly, the biggest single risk for financial markets now
is the failure of vaccines being rolled out smoothly in Q1
2021," wrote MUFG strategist Derek Halpenny.

"The other key risk that also continues to be ignored is the
ongoing surge in COVID infections and deaths in the US," he
said, adding that if President-elect Joe Biden brings in new
lockdown restrictions while the rest of the world is recovering
next year then that provide a further reason to sell the dollar.

Dollar-yen was down 0.1% at 104.16 at 1215 GMT.
China's offshore yuan was on track for its first week of net
losses versus the dollar this month.

The euro was up 0.1% at $1.19185, having shown
little reaction to downbeat comments from the European Central
Bank's chief economist Philip Lane on Thursday.

With market participants long on the euro, Rabobank's Foley
said that euro-dollar could face downsides as the ECB has
signalled that it is watching euro appreciation. The EU budget
which includes the COVID-19 recovery fund has not yet been
approved.

“The market hasn’t yet reacted to the Hungary/Poland issue -
the vetoing of the budget," she said. “The market might be
underestimating that battle.”
(Reporting by Elizabeth Howcroft; Editing by Simon
Cameron-Moore and Chizu Nomiyama)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.